v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Total revenues $ 14,063 $ 7,902
Operating costs and expenses:    
Cost of revenues 655 1,269
Research and development 22,759 71,734
Selling, general and administrative 57,591 52,574
Restructuring 513 597
Total operating costs and expenses 81,518 125,577
Loss from operations (67,455) (117,675)
Interest income, net 5,223 9,204
Other income (expense), net 18 (12)
Net loss $ (62,214) $ (108,483)
Net loss per share - basic $ (1.01) $ (1.8)
Net loss per share - diluted $ (1.01) $ (1.8)
Weighted average number of common shares outstanding— basic 61,857,573 60,136,198
Weighted average number of common shares outstanding— diluted 61,857,573 60,136,198
Comprehensive loss:    
Net loss $ (62,214) $ (108,483)
Other comprehensive items:    
Unrealized gain on marketable securities (102) 27
Total comprehensive loss (62,316) (108,456)
Product Revenue [Member]    
Total revenues   1,690
Collaboration Revenue - Related Party [Member]    
Total revenues 13,827 $ 6,212
Other Revenue [Member]    
Total revenues $ 236